Regulatory advocacy update: American society of plastic surgeons comments in response to the U.S. food and drug administration draft guidance documents on human cell and tissue products

J. Peter Rubin, Richard A. D'Amico, Ricardo Rodriguez, Sydney R. Coleman, Paul Cederna, Scot Glasberg, Michael Neumeister, David H. Song, Charles Butler, Keith M. Hume

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The U.S. Food and Drug Administration released draft guidance documents on human cells, tissues, and cellular and tissue-based products regulations. These proposed guidance documents can impact the practice of plastic surgery in the area of tissue grafting procedures. This article describes the relevant issues in these draft guidance documents, and presents the comments provided to the U.S. Food and Drug Administration by the American Society of Plastic Surgeons.

Original languageEnglish
Pages (from-to)1259-1261
Number of pages3
JournalPlastic and Reconstructive Surgery
Volume139
Issue number5
DOIs
StatePublished - 1 May 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Regulatory advocacy update: American society of plastic surgeons comments in response to the U.S. food and drug administration draft guidance documents on human cell and tissue products'. Together they form a unique fingerprint.

Cite this